Kinnevik AB (publ)
Q1 2025 13F Holdings
- Locationstockholm, V7
- Num holdings
1
- Value ($000)
$71,067
- Date Filed04/28/2025
- Form type13F-HR
- CIK0001766574
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
---|---|---|---|---|---|---|---|
RXRX Recursion Pharmaceuticals, Inc. | CL A | 75629V104 | $71.07 M | 100 % | 13,434,171 |
Rows Per Page
10
- 10
- 50
- 100